Piramal Group is a global diversified business conglomerate with operations in over 30 countries and a strong presence in more than 100 markets around the world. Since the late 1980s, Piramal Group has evolved from a textile-centric business to a diversified organization, which operates across sectors such as pharma, health care information management, financial services, specialty glass packaging and real estate.
As a Group we have consistently identified opportunities ahead of the curve, even when market situations suggest the opposite. We invested in the domestic formulations business when others were focused on growing international generics. Our persistence paid off when a deal with Abbott in 2010 valued our business at US$3.72 billion, an unprecedented 9x sales and 30x EBITDA.
Over the past two decades, our Group has consistently focused on growth and today is ranked amongst the leading business conglomerates in India. The approach has been both organic and inorganic growth. We have built solid global partnerships to augment our presence in certain markets and continue to focus on core businesses by consistently investing in them. Piramal Group’s balance sheet today is in excess of US$9.5 billion and over 60 percent of the revenues are generated from outside India. We are home to a team of over 10,000 people from around the world and at all times have over 21 nationalities working with us. Our philanthropic arm, Piramal Foundation, runs projects across healthcare, education and water . Projects like Piramal Sarvajal and e-Swasthya are now Harvard Business School Case Studies.
